🔗 Share this article

An underground market for unapproved slimming medications is propelled by social media fitness personalities and vendors on messaging platforms, based on new investigations.

Investigational Drug Acquiring Traction Online

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to message these accounts directly for source information, while also receiving promotional offers.

Active Trade on Messaging Platforms

Separately, a robust trade exists on messaging services, where communities with thousands of members share comparison images, injection guides and claims of next-day UK delivery. Vendors promote the substance there before directing customers to other platforms for transactions.

Understanding Retatrutide

This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Medical Experts Express Concerns

However, physicians and chemists have cautions that the distribution of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in users administering substances of uncertain source.

Several experts said the popularity for retatrutide could be connected to the increasing cost of licensed weight loss products such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that must not be marketed or distributed for human use under the British medical regulations.

Some influencers try to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still violate medicines, marketing, and consumer laws, risking penalties, prosecution or prison.

Platform Response and Material Removal

According to TikTok, the service has taken down problematic content and banned associated keywords and search suggestions. The company said it was dedicated to keeping the platform safe and investing in strengthening compliance measures.

Online Trading Activities

Investigations also found communities with up to nine thousand members selling the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays groups with numerous of members, filled with images of weight loss, positive testimonials and detailed instructions for preparing or injecting at home.

After minutes of entering one community, a seller shared WhatsApp details, where the majority of transactions occur. The vendor sent an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. None inquired about body mass, health issues or previous experience.

Product Information and Pricing

Within these communities, posts display black plastic parcels with postal service labels, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with sterile water, or pre-filled injectors typically sold at £160 for 20 milligrams. When questioned how much time a injector should be used, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Service Oversight and Safety Actions

A spokesperson for Telegram said it actively monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are administering substances they can’t verify. Although the research behind this drug is sound, these online versions may not include what they advertise,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in demand to recent price rises for authorized weight-loss medications such as Mounjaro. “With costs increasing, individuals are using social media. But fake treatments are highly risky. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she explained.

Her staff has previously seen individuals injured by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company investigational product not yet approved … may expose patients to possibly significant medical dangers”.